What You May Have Missed: Top Biotech Stories for the Month of AugustAllbiopro2018-09-01T14:40:54+09:009월 1st, 2018|
AstraZeneca’s Lupus Drug Flunks Phase III Clinical TrialAllbiopro2018-09-01T14:40:17+09:009월 1st, 2018|
Eli Lilly Taps Anne White to Take Over Oncology DivisionAllbiopro2018-09-01T14:39:40+09:009월 1st, 2018|
Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in DogsAllbiopro2018-09-01T14:38:29+09:009월 1st, 2018|
Can Amgen’s new-and-improved Kyprolis kick-start myeloma sales?Allbiopro2018-09-01T14:37:22+09:009월 1st, 2018|
GlaxoSmithKline revives Bexsero’s meningitis B moms in renewed back-to-college TV pushAllbiopro2018-09-01T14:36:52+09:009월 1st, 2018|
Lilly hands its oncology baton—and big ambitions—to R&D executive Anne WhiteAllbiopro2018-09-01T14:36:17+09:009월 1st, 2018|
Fosun Pharma ‘massively’ fakes API production data and bribes regulators, whistleblower saysAllbiopro2018-09-01T14:35:44+09:009월 1st, 2018|
Valsartan probe teaches FDA lesson about impurities in manufacturingAllbiopro2018-09-01T14:35:06+09:009월 1st, 2018|
Chasing top HIV players, Merck scores FDA approval for 2 new drugsAllbiopro2018-09-01T14:34:35+09:009월 1st, 2018|
CRISPR Therapeutics, Vertex start first company-backed human CRISPR trialAllbiopro2018-09-01T14:33:27+09:009월 1st, 2018|
Thwarting cancer by targeting cell survival and growthAllbiopro2018-09-01T14:32:24+09:009월 1st, 2018|
Another setback for AstraZeneca as lupus drug fails phase 3 testAllbiopro2018-09-01T14:31:50+09:009월 1st, 2018|
Sartorius opening life sciences launchpad to grow German talent and innovationAllbiopro2018-09-01T14:31:16+09:009월 1st, 2018|
